Clinical Trials Logo

Epstein-Barr Viraemia clinical trials

View clinical trials related to Epstein-Barr Viraemia.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03769467 Terminated - Clinical trials for Nasopharyngeal Carcinoma

Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)

Start date: February 19, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

This is a multicenter, open-label, single-arm Phase 1B/2 study to assess the safety and efficacy of tabelecleucel in combination with pembrolizumab for the treatment of subjects with platinum-pretreated, recurrent/metastatic Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC).